ESC 365 - Myocardial phenotype of patients with indications for secondary prevention implantable cardioverter defibrillator therapy: insights from cardiovascular magnetic resonance

EHRA Premium Access

Myocardial phenotype of patients with indications for secondary prevention implantable cardioverter defibrillator therapy: insights from cardiovascular magnetic resonance

Session: Poster session 1 - Antibradycardia Pacing

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor A. Zegard (Birmingham, GB)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Doctor Abbasin Zegard

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

21 more presentations in this session

Heart failure risk in patients with chronic right ventricular pacing: an observational study

Speaker: Professor B. Kichou (Tizi-ouzou, DZ)

Electrophysiological assessment of His-bundle pacing

Speaker: Doctor D. Yoshimoto (Toyohashi, JP)

Biatrial pacing using a canted left ventricular lead in the distal coronary sinus: one-year results from a series of six cases

Speaker: Mr M. Schrage (Berlin, DE)

Improving the safety and efficiency of CIED implantation procedures with pre-procedural contrast-enhanced venography

Speaker: Assistant Professor J. Taleski (Skopje, MK)

Importance of RV lead placement in patients undergoing pacemaker implantation with expected high RV pacing and the development of heart failure and early detection in cardiac MRI

Speaker: Doctor V. Johnson (Frankfurt, DE)

Access the full session

Poster session 1 - Antibradycardia Pacing

Speakers: Doctor A. Zegard, Professor B. Kichou, Doctor D. Yoshimoto, Mr M. Schrage, Assistant Professor J. Taleski...

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources